Evaluation of the prognostic significance of RACGAP1, Ki67, and TOP2A mRNA expression in high-risk early breast cancer.

Authors

null

Kyriaki Pliarchopoulou

Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece

Kyriaki Pliarchopoulou , Helen Gogas , Christos A. Papadimitriou , Ralph M Wirtz , George Kouvatseas , Eleni Timotheadou , Flora Stavridi , Christos Christodoulou , Angelos Koutras , Nikolaos Pisanidis , George E. Pentheroudakis , Dimitris Bafaloukos , Epaminontas Samantas , Konstantine T. Kalogeras , Meletios A. Dimopoulos , Dimitrios G. Pectasides , George Fountzilas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Citation

J Clin Oncol 31, 2013 (suppl; abstr 582)

DOI

10.1200/jco.2013.31.15_suppl.582

Abstract #

582

Poster Bd #

6E

Abstract Disclosures